Metraipolis › archive › dc_734f455d7991

Emerging Therapies for Sickle Cell Disease: From Symptom Management to Curative Gene Therapy — Europe PMC PMID:41281092

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41281092
DOI
10.7759/cureus.95112
License (as archived)
solo-consultazione
Archived
2026-11-09T04:13:35.381Z
SHA-256 of the archived text
c0a76070b6a18ee2ad12b9cc44f5bf4f73200cdc843ce79f44112333fd405c9c
Stable URL of this page
https://metraipolis.com/documento/dc_734f455d7991

How to cite

Emerging Therapies for Sickle Cell Disease: From Symptom Management to Curative Gene Therapy — Europe PMC PMID:41281092 — Europe PMC (en), https://europepmc.org/article/MED/41281092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_734f455d7991 (Metraipolis archive dc_734f455d7991, sha256 c0a76070b6a18ee2ad12b9cc44f5bf4f73200cdc843ce79f44112333fd405c9c)
BibTeX
@misc{dc734f455d7991,
  title = {Emerging Therapies for Sickle Cell Disease: From Symptom Management to Curative Gene Therapy — Europe PMC PMID:41281092},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41281092},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_734f455d7991; sha256 c0a76070b6a18ee2ad12b9cc44f5bf4f73200cdc843ce79f44112333fd405c9c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41281092. Agents can read the archived copy with the MCP tool read_document.